001     144612
005     20230425171544.0
024 7 _ |a 10.1016/B978-0-444-63486-3.00011-6
|2 doi
024 7 _ |a 0079-6123
|2 ISSN
024 7 _ |a 1875-7855
|2 ISSN
024 7 _ |a altmetric:2930740
|2 altmetric
024 7 _ |a pmid:25410361
|2 pmid
037 _ _ |a DZNE-2020-00124
082 _ _ |a 610
100 1 _ |a Pitkänen, Asla
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Neural ECM and epilepsy
260 _ _ |a Amsterdam [u.a.]
|c 2014
|b Elsevier
295 1 0 |a Brain Extracellular Matrix in Health and Disease / Pitkänen, Asla ; : Elsevier, 2014, ; ISSN: 00796123 ; ISBN: 9780444634863 ; doi:10.1016/B978-0-444-63486-3.00011-6
300 _ _ |a 229 - 262
336 7 _ |a BOOK_CHAPTER
|2 ORCID
336 7 _ |a Book Section
|0 7
|2 EndNote
336 7 _ |a bookPart
|2 DRIVER
336 7 _ |a INBOOK
|2 BibTeX
336 7 _ |a Output Types/Book chapter
|2 DataCite
336 7 _ |a Contribution to a book
|b contb
|m contb
|0 PUB:(DE-HGF)7
|s 1591362006_14122
|2 PUB:(DE-HGF)
490 0 _ |a Progress in Brain Research
|v 214
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef Book Series
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Anticonvulsants: therapeutic use
|2 MeSH
650 _ 2 |a Epilepsy: drug therapy
|2 MeSH
650 _ 2 |a Epilepsy: metabolism
|2 MeSH
650 _ 2 |a Epilepsy: pathology
|2 MeSH
650 _ 2 |a Extracellular Matrix: drug effects
|2 MeSH
650 _ 2 |a Extracellular Matrix: physiology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Receptors, Urokinase Plasminogen Activator: drug effects
|2 MeSH
650 _ 2 |a Receptors, Urokinase Plasminogen Activator: metabolism
|2 MeSH
700 1 _ |a Ndode-Ekane, Xavier E.
|b 1
700 1 _ |a Łukasiuk, Katarzyna
|b 2
700 1 _ |a Wilczynski, Grzegorz M.
|b 3
700 1 _ |a Dityatev, Alexander
|0 P:(DE-2719)2810577
|b 4
|u dzne
700 1 _ |a Walker, Matthew C.
|b 5
700 1 _ |a Chabrol, Elodie
|b 6
700 1 _ |a Dedeurwaerdere, Stefanie
|b 7
700 1 _ |a Vazquez, Naiara
|b 8
700 1 _ |a Powell, Elizabeth M.
|b 9
773 _ _ |a 10.1016/B978-0-444-63486-3.00011-6
909 C O |o oai:pub.dzne.de:144612
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2810577
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|2 G:(DE-HGF)POF3-300
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2014
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PROG BRAIN RES : 2018
|d 2020-01-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-01-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
|d 2020-01-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
|d 2020-01-15
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
|d 2020-01-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-15
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-01-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-01-15
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2020-01-15
920 1 _ |0 I:(DE-2719)1310007
|k AG Dityatev
|l Molecular Neuroplasticity
|x 0
980 _ _ |a contb
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1310007
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21